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abstract
Systemic sclerosis (SSc) is an autoimmune disorder of
unknown etiology characterized by early impairment of
the microvascular system. Nailfold microangiopathy
and decreased peripheral blood perfusion are typical
clinical aspects of SSc. The best method to evaluate vas-
cular injury is nailfold videocapillaroscopy, which de-
tects peripheral capillary morphology, and classifies and
scores the abnormalities into different patterns of mi-
croangiopathy. Microangiopathy appears to be the best
evaluable predictor of the disease development and has
been observed to precede the other symptoms by many
years. Peripheral blood perfusion is also impaired in
SSc, and there are different methods to assess it: laser
Doppler and laser speckle techniques, thermography
and other emerging techniques.
Keywords: Capillaries; Systemic sclerosis; Raynaud’s
phenomenon; Scleroderma
iNtroductioN
Several rheumatic diseases are characterized by structu -
ral and functional alterations of microcirculation, with
important clinical implications from the beginning up
to the progression1,2. Microvascular damage and dys-
function represent the earliest morphological and func-
tional markers of systemic sclerosis (SSc). The vascular
changes represent an early event in SSc and Raynaud’s
phenomenon (RP), observed in over 90% of patients,
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constitutes the clinical expression of altered blood flow
regulation due to microvascular damage1,2. Microan-
giopathy can be easily studied by nailfold videocapil-
laroscopy (NVC), which is the best method to assess
the early differentiation between primary and sec-
ondary Raynaud phenomenon and to classify the prop-
er pattern of microvascular damage (“Early”, “Active”,
or “Late” pattern), and to calculate the microangiopa-
thy evolution score (MES)3,4. Since 2013 the NVC pat-
terns are included in the European League Against
Rheumatism and American College of Rheu matology
criteria of SSc5. In standard conditions NVC, which
evaluates capillary morphology, cannot measure blood
perfusion6. However, the assessment of blood perfu-
sion in SSc may be performed by different laser tech-
niques: laser Doppler flowmetry (LDF), laser doppler
imaging (LDI), laser speckle contrast ima ging (LSCI)
and laser speckle contrast analysis (LASCA)7-10. The use
of NVC together with laser techniques, all safe and non-
-invasive tools, allows the morphologi cal and func-
tional assessment of the peripheral microvasculature
that is a must for diagnosis, prognosis and therapy in
SSc patients.
The aim of this literature review is an over view of
the different morphological and functional techniques,
that allow to study and follow the microvascular dam-
age.
Nailfold videocapillaroscopy
Nailfold videocapillaroscopy (NVC) is a safe and non-
invasive technique to assess the morphology of nailfold
dermal capillaries using a magnification system (len ses
magnification ×200). Videocapillaroscopy consists of
the combination of an optical microscope with a digi -
tal video camera. The patient undergoing the exam
must initially remain seated in an acclimatized room
for 15-20 minutes, with a temperature set around 22-
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-23° C. For a better visualization of the capillaries and
the refractive defect reduction, a drop of immersion
(cedar) oil is placed on the cuticle of the fingers to be
evaluated. The periungual region of eight out of ten
fingers (excluding the thumb, because of a lowest
transparency due to the nail width and the absence of
distal phalanx) should be examined. In this region, the
distal row of capillary loops protrudes into the dermal
papillae, allowing a longitudinal view of the capillary
segments (afferent, efferent and transition), as arranged
in a direction parallel to the skin surface1,11.
Through NVC qualitative assessment a normal
capil lary pattern can be distinguished from an abnor-
mal pattern. Important capillaroscopic parameters are:
skin transparency, visibility and morphology of sub-
papillary venous plexus, number of capillaries inside
each dermic papilla, disposition of the capillaries in
the nailfold bed, capillary morphology (regular hair-
pin-shaped, tortuousities, dystrophies, ectasias, giant
capillaries), occurrence of ramifications, presence of
hemorrhages or hemosiderin deposits, and capillary
density11,12.
Capillary density is considered normal if the num-
ber of capillaries exceeds 9 per linear millimetre (ave -
rage range: 9-12 capillaries per mm). The number of
capillaries could be slightly decreased in the early
phase of SSc, while the considerable and progressive
capillary desertification is a diagnostic feature of
advan ced SSc microangiopathy2,13.
In their normal disposition capillaries are parallel
to each other, in number of one (rarely two) per der-
mal papilla, and perpendicularly oriented to digital
surface. The normal capillaroscopic pattern, by quali -
tative assessment, is characterized by a homogeneous
distribution of hairpin-shaped capillaries as a “comb-
-like structure”.
The capillary is defined as ectasic when it shows a
localized dilation ≥ 20 µm (but < 50 µm); if the dila-
tion has an homogeneous aspect (involving both affe -
rent and efferent branches), exceeding 50 µm, the ves-
sel is defined as a giant capillary. In a recent study, our
group demonstrated that abnormal dilations of capil-
lary diameter (>30micrometer) at the level of arterial
and/or venous branches, were significantly expressed
in subjects diagn osed with primary Raynaud phe-
nomenon (PRP) subjects that would later develop sec-
ondary Raynaud phenomenon (SRP), associated with
SSc. Furthermore, over at least 3.56 years of follow up,
the progressive presence of abnormal capillary dila-
tions in PRP subjects, should be considered as a pos-
sible very early NVC signal of transition to the “early”
scleroderma pattern14.
Hemosiderin deposits (microhemorrhages) are as-
sociated with early vascular damage, as well as their
presence represents a transition phase between giant
capillaries and the subsequent loss of capillaries. On
the other hand, the modification of the normal archi-
tectural arrangement represents an early morphologi-
cal feature in SSc and other connective tissue diseases
of the scleroderma-spectrum disorders2,11,12. Although
typical of microvasculopathy, the microhemorrhages,
are not specific of the scleroderma spectrum diseases
and can be found in other connective tissue diseases,
such as SLE or antiphospholipid syndrome1,11.
Either in normal conditions or in PRP the nailfold
capillaroscopic pattern shows regular disposition of
capillary loops along the nailfold bed and no abnormal
enlargements or capillary loss1,12. In patients with RP,
however, one or more abnormal capillaroscopic fin -
dings should alert the physician to the possibility of
SRP, owing to the pre sence of a previously undetected
connective autoimmune disease1,11.
In healthy subjects the NVC pattern is characteri zed
by: normal skin transparency, morphology of the ca -
pilla ry to “U” or “hairpin shape”, morphologi cal/
/structu ral homogeneity, 10-12 capillaries/mm, one
capillary/dermal papilla, diameters of capillary bran -
ches <20 μm and lack of morphological atypia. Fur-
thermore, in healthy subjects three different capillary
morphologies may be observed. The first category is
stereotype hairpin shape which is present in 50% of
healthy subjects; another category is called “nonspe-
cific variations” which are tortuosities that occur in
40% of controls; the third category represents crossing
capillaries which are present in 8% of control. This
variations could be influenced by job, trauma, age,
onychophagy, manicures, exposure to chemical subs -
tances and individual physiological variability1,2,11,12,15.
In PRP nailfold capillaries are frequently normal,
but it is possible to observe capillaries with effe rent
branch enlargement or tortuous capillaries.
Conversely, SRP is characterized by the morpho-
logical signs that represent microvascular damage,
these include giant capillaries, microhaemorrhages,
capillary loss, the presence of avascular areas and an-
giogenesis. These sequential capillaroscopic changes
are typical of the microvascular involvement observed
in more than 95% of SSc patients and des cribed by the
term ‘scleroderma-pattern1,2,11.
NVC technique identifies morphological patterns
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that may present the scleroderma pattern of nailfold
microangiopathy are mainly mixed connective tissue
disease and dermatomyositis; however, undifferenti-
ated connective tissue diseases and lupus erythemato-
sus may display a such pattern in limited cases1,2,11. As
matter of fact, specific capillaroscopic patterns are pre-
sent only in systemic sclerosis.
NVC is also used to make a quantitative assessment
(i.e. quantify certain characteristics and make semi-
quantitative scoring) of the microvascular damage. The
usual capillaroscopic parameters can been evaluated
by a semi-quantitative scale, consisting of diagnostic
parameters (irregularly enlarged capillaries, giant capil -
laries, micro-haemorrhages) and progression parame-
ters (reduced capillary number, capillary ramifications
and capillary architectural disorganization). Score 0-3
is adopted for all these parameters (score 0: no
changes; score 1: <33% of capillary changes; score 2:
33% to 66% of capillary changes; score 3: >66% of
capillary changes). The mean score value for each ca -
pillaroscopic parameter is calculated from the analysis
of at least two linear millimetres in the middle area of
the nailfold bed, in each finger; the score values from
the eight fingers are added together, and the final va -
lue divided for eight fingers. The resulting value repre -
sents the score for each capillaroscopic parameter ana -
lyzed. An abnormal capillaroscopic finding should be
specific to various stages of SSc (‘Early’, ‘Active’ and
‘Late’ patterns)3,4,11. The ‘Early’ SSc pattern is characte -
rized by few enlarged and giant capillaries, few ca -
pillary microhaemorrhages, no evident capillary loss
and a relatively well preserved capillary distribution.
The ‘Active’ SSc pattern, a marker of disease progres-
sion, is characterized by frequent giant capillaries, fre-
quent (more than 6 per millimetre) capillary micro-
haemorrhages, moderate (20-30%) capillary loss, 
absent or mild ramified capillaries and a mild disorga-
nization of the capillary architecture. In the ‘Late’ SSc
pattern, although giant capillaries and microhaemor-
rhages are almost absent, there is irregular enlargement
of the capillaries, severe (>50%) capillary loss with evi -
dent extensive avascular areas, ramified or bushy
capilla ries and a severe disorganization of the capillary
array3,4,11 (Figure 1).
The ‘scleroderma-like’ pattern is defined as a capil-
lary pattern showing mixed microvascular markers of
the scleroderma capillary patterns, but not fully fitting
the definition for the single ‘Early’, ‘Active’ and ‘Late’
scleroderma pattern3,4,11. It may be found in those cli -
 nical conditions included into the scleroderma-spec-
trum diseases category, which is defined as having ei-
ther an ‘Early’, ‘Active’ and ‘Late’ scleroderma pattern
or a “scleroderma-like“ pattern of nailfold microan-
giopathy3,4,11. The clinical conditions other than SSc
fiGure 1. Nailfold videocapillaroscopy images (x200) in healthy subject (A), ‘Early’ (B), ‘Active’ (C)and ‘Late’ (D) patterns of 
scleroderma microangiopathy. Academic Division of Clinical Rheumatology – Genova, operator PC
a b 
c d
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considered significant if it is observed in at least two
fingers of the subject, but in the case of giant capilla -
ries their presence is highly predictive of a scleroder-
ma-spectrum disease, even if detected in only one fin-
ger3,4,11. In this last case a short follow-up is recom-
mended2.
The ‘‘microangiopathy evolution score’’ (MES, sum
of scores of progression parameters; score 0-9) is used
to assess the vascular damage progression, as the scores
of its parameters were demonstrated to significantly
increase during the evolution of the SSc microan-
giopathy3,4.
cliNical applicatioNs of 
capillaroscopy iN systemic sclerosis
NVC represents the best and validated method to as-
sess the vascular damage in SSc.
For this reason, abnormal capillaroscopy is inclu ded
among the parameters of the 2013 ACR/EULAR clas-
sification criteria, the 2001 LeRoy criteria for the clas-
sification of early systemic sclerosis and the 2013 VE-
DOSS criteria for very early diagnosis of SSc5,16,17.
NVC analysis allows the detection of microvascular
markers of severity and progression in SSc, such as re-
duced capillary density, which has been associated
with a high risk of developing digital ulcers and pul-
monary arterial hypertension13,14.
The utility of NVC to predict digital ulcers (DU) is
presented in the CAP study. CAP study is the first
largest (500 patients), multicenter (70 centers), obser -
vational, clinical study with the aim of identifying NVC
variables and clinical characteristics which predict the
occurrence of new DU in SSc patients. The prelimi-
nary results of CAP study have been recently presen -
ted, and the study showed that the strongest predictors
for new DU in SSc patients with DU history were NVC
variables reflecting SSc microvasculopathy (mainly
capillary number) and the number of DU at enrolment.
The study showed that NVC imaging and assessment
are feasible in multicentre trials18.
NVC may be used also to monitor the effects of the -
rapies in SSc treatment19,20.
Treatments proven in vitro to interfere with en-
dothelial cell functions and/or influencing mediators of
the endothelial to mesenchymal cell transition (En-
doMT), such as endothelin-receptor antagonists (ERA)
that are involved in the fibrotic process, were found
effective in preventing new DU in scleroderma, as well
as to interfere with SSc microangiopathy progres-
sion21,22. The long term treatment with ERA in combi-
nation with a vasodilator (iloprost) of SSc patients af-
fected by DU, was found to interfere with the evolu-
tion of the microvascular damage after at least one year,
as assessed by both NVC and peripheral blood flow
analysis22,23.
Furthermore, immune-suppression with cyclo -
phosphamide was demonstrated, by NVC, to improve
the SSc nailfold microangiopathy24,25.
capillaroscopy aNd aNalysis of 
peripheral blood flow
Capillary blood flow/perfusion cannot be quantita-
tively measured by NVC in standard conditions, as
only a qualitative evaluation may be performed. Blood
flow may be assessed by NVC only as regular, granu-
lous, or stasis6.
The real assessment and quantification of cutaneous
blood perfusion in SSc may be performed by different
laser techniques (see below)7. Also, thermography was
employed to assess skin blood flow, and emerging
technologies (e.g. optical Doppler tomography and
spectroscopy) are under evaluation7,26.
differeNt laser techNiques to aNalyse
the peripheral blood flow 
The different laser techniques most commonly used to
assess vascular impairment in SSc are: laser Doppler
flowmetry (LDF), that assesses and quantifies the
blood perfusion at a single skin point (one mm3); laser
Doppler imaging (LDI), that measures blood flow of an
area; laser speckle contrast imaging (LSCI), that quick-
ly measures blood flow of an area (the contrast is cal-
culated based on one pixel in a time sequence); laser
speckle contrast analysis (LASCA), that quickly quan-
tifies the blood flow of an area (the contrast is calcu-
lated based on multiple pixels in one image), allowing
analysis of specific areas in a second time7,8,26,27.
capillaroscopy aNd laser doppler 
LDF is a non-invasive and user-friendly method, which
provides an index of skin perfusion by measuring the
Doppler shift induced by coherent light scattering
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caused by moving red blood cells. LDF evaluates mi-
crovascular flow in perfusion units (PU) at a single skin
point7. With LDF it is possible to assess the basal fin-
ger temperature (usually at the level of fingertips from
2nd to the 5th digit on both hands), and the capillary di-
lation capacity after having heated the probe to 36°C23.
Some studies have demonstrated that SSc patients
have a lower blood flow than both healthy subjects
and primary RP patients and that patients with the
‘Late’ SSc pattern of microangiopathy on NVC had a
lower blood flow at LDF than patients with ‘Active’
and ‘Early’ NVC patterns23. SSc patients have also an
abnormal microvascular regulatory response to heat
stimulation23.
Cutolo et al., in two studies have demonstrated that
LDF is also efficacious for the evaluation of the varia-
tion of peripheral blood perfusion during treatment
with vasoactive drugs within a few days or even over a
long follow-up period of years22,23. In SSc patients, the
correlation between blood perfusion, evaluated by LDF,
and dermal thickness, measured by high frequency ul-
trasound, was also demonstrated at the finger level9.
One disadvantage of this technique is the large site-
-to-site variation, which limits its efficacy in compa ring
blood flows between sites and in monitoring change
over time22,23.
Laser Doppler imaging (LDI), which evaluates
blood flow over a skin area might overcome this pro -
blem7,27. In their article Murray et al demonstrated that
NVC, LDI, and thermal imaging each independently
provide good discrimination between patients with SSc
and those with primary RP and healthy controls7.
capillaroscopy aNd laser speckle 
coNtrast techNiques 
Laser speckle contrast analysis (LASCA) is a non-con-
tact technique that has also the advantages to quanti-
fy the blood perfusion (in perfusion units, PU) over an
area (Figure2). With LASCA it is also possible to cre-
ate different regions of interest (ROI) and time regions
of interest (TOI) to evaluate the blood perfusion10.
LASCA is based on the principle that when an 
object is illuminated by laser light, the backscattered
light will form a random interference pattern made up
of dark and bright areas. This pattern is the so-called
speckle pattern and is stationary. When movement 
occurs, as in red blood cells in tissue, the speckle pat-
tern will change over time and these changes will be
recor ded by a detector camera28.
LASCA has been applied in research studies on RP
and SSc10,29,30. One such study demonstrated that pe-
ripheral blood perfusion evaluated by LDF and LAS-
CA correlates to the extent of the microangiopathy10.
It also reported that when evaluated by both methods,
patients with the ‘late’ SSc microangiopathy pattern
had a lower blood flow than patients with the ‘Active’
or ‘Early’ SSc patterns on NVC10.
In another study by LASCA technique, blood per-
fusion was found significantly lower in SSc patients in
comparison with healthy subjects at the level of fin-
gertips, periungual areas, and palm of hands, and a
statistically significant negative correlation was obser -
ved between nailfold microangiopathy extent and
blood perfusion values at the level of the same skin 
areas in SSc patients29.
Furthermore, LASCA may safely monitor digital ul-
cers evolution in SSc patients, by evaluating their
blood perfusion and area during the treatment31.
thermoGraphy aNd other emerGiNG
techNiques
Thermal imaging, or infrared thermography, is a
method that indirectly evaluates the blood perfusion,
by using a thermal camera to image the temperature of
the skin. This was shown to be representative of un-
derlying blood flow7. Murray et al used thermography,
LDI and NVC to studies the vascular response of pa-
tients with SSc and primary RP compared with healthy
controls. In conclusion they observed that the combi-
nation of all 3 techniques improves classification of
fiGure 2. Laser speckle contrast analysis images of the hand
dorsal aspect of the hand in healthy subject (A) and patient
with a “Late” pattern of scleroderma microangiopathy (B). Blue
colour = low blood perfusion, yellow colour = intermediate
blood perfusion, red colour = high blood perfusion. Academic
Division of Clinical Rheumatology – Genova, operator RB
a b
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SSc patients and that LDI and thermal imaging give
similar information on dynamic changes in the cuta-
neous microcirculation7.
Other emerging technologies for example Doppler
optical coherence tomography, photoacoustic tomo -
graphy and hyperspectral imaging are potential tech-
niques that could become established tools for clinical
microvascular assessment26.
coNclusioNs 
NVC is currently the only validated method to detect
peripheral microvascular morphology, and allows to
classify and to score the capillary abnormalities in SSc
patients32. Furthermore, it is the validated method to
distinguish between primary and secondary RP, and to
follow-up SSc microangiopathy. 
Interestingly, the recent inclusion of capillaroscopy
among the diagnostic tools for the ACR/EULAR clas-
sification criteria of SSc, has been found to increase
their sensitivity and specificity5.
Laser Doppler and laser speckle techniques repre-
sent the best tools to assess and quantitate periphe ral
blood flow/perfusion, showing good correlations with
capillaroscopy analysis10,30,33,34.
The growing interest in the microcirculation caused
a rapid development of new methods for its assess-
ment, but all new techniques require studies for its va -
lidation in clinical practice.
The use of NVC together with LDF and LASCA re -
presents an essential set of safe and non-invasive tools
for identification, quantification and monitoring of SSc
microangiopathy. The use of these tools in rheumatolo -
gy clinics allows to improve the detection of the SSc
microvascular status and possible effects of the thera-
peutic intervention.
It would be therefore desirable that these techniques
had a wide diffusion in the rheumatological clinical
practice.
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